STRATA Skin Sciences (SSKN) Cash from Investing Activities Growth (3y) (2013 - 2025)
STRATA Skin Sciences (SSKN) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -472.46% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | -16.93% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -111.03% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | -40.94% |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | 43.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.16% |
| Sep 30, 2025 | -24.54% |
| Jun 30, 2025 | 27.52% |
| Mar 31, 2025 | 46.64% |
| Dec 31, 2024 | 23.60% |
| Sep 30, 2024 | 76.08% |
| Jun 30, 2024 | 21.96% |
| Mar 31, 2024 | 0.68% |
| Dec 31, 2023 | -34.13% |
| Sep 30, 2023 | 31.44% |
| Jun 30, 2023 | -133.37% |
| Mar 31, 2023 | -44.33% |
| Dec 31, 2022 | -6.26% |
| Sep 30, 2022 | -7.60% |
| Jun 30, 2022 | -17.06% |
| Mar 31, 2022 | -44.52% |
| Dec 31, 2021 | -31.06% |
| Sep 30, 2021 | -130.69% |
| Jun 30, 2021 | -12.57% |
| Mar 31, 2021 | -22.25% |